Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar mrwrong (< 20) Submitted: 3/29/2014 2:06:48 PM : Underperform Start Price: $129.27 VRX Score: +12.94

growth will stall as company comes a cropper, with a bridge too far. most all- do, but i like it now.

Featured Broker Partners


Advertisement